RB1 loss-of-function mutations in post-Osimertinib NSCLC and prognostic implications
Post-Osimertinib RB1 loss-of-function mutations are associated with worse prognosis in NSCLC
A) 
B)
Figure 1. A) Real-world overall survival, anchored on biopsy date, for patients with a post-Osimertinib biopsy prior to intervening therapy. Kaplan-Meier curve stratified on presence of RB1 loss of function. B) Cox regression model including both RB1 and TP53 loss of function.
Lens Library
